Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PUL-042 for Viral Infections in Hematologic Malignancies and HSCT Recipients
NCT06665100Phase 2Recruiting
- Sponsor
- Pulmotect
- Start
- Jun 2025
- Primary completion
- Apr 2027
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of PUL-042 in viral infection, 19p13.3 microduplication syndrome, sponsored by Pulmotect. Started Jun 2025; status: recruiting.
02
Drugs
PUL-042
03
Conditions
viral infection19p13.3 microduplication syndrome
Beyond the preview
Go deeper on NCT06665100.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06665100.